115 related articles for article (PubMed ID: 3514240)
1. Kinetics of cellular oncogene expression in mouse lymphocytes. I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens.
Schneider-Schaulies J; Hünig T; Schimpl A; Wecker E
Eur J Immunol; 1986 Mar; 16(3):312-6. PubMed ID: 3514240
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.
Schneider-Schaulies J; Schimpl A; Wecker E
Eur J Immunol; 1987 May; 17(5):713-8. PubMed ID: 3556196
[TBL] [Abstract][Full Text] [Related]
3. Defective T lymphocytes in old mice. Diminished production of mature c-myc RNA after mitogen exposure not attributable to alterations in transcription or RNA stability.
Buckler AJ; Vie H; Sonenshein GE; Miller RA
J Immunol; 1988 Apr; 140(7):2442-6. PubMed ID: 3280682
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Shipp MA; Reinherz EL
J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
[TBL] [Abstract][Full Text] [Related]
5. Activation of murine CD8+ lymphocytes: two distinct signals regulate c-myc and interleukin 2 receptor RNA expression.
Hardt C
Eur J Immunol; 1987 Dec; 17(12):1711-7. PubMed ID: 3121357
[TBL] [Abstract][Full Text] [Related]
6. Cellular oncogenes and lymphocyte activation.
Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression.
Reed JC; Alpers JD; Scherle PA; Hoover RG; Nowell PC; Prystowsky MB
Oncogene; 1987 May; 1(2):223-8. PubMed ID: 3501855
[TBL] [Abstract][Full Text] [Related]
8. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
[TBL] [Abstract][Full Text] [Related]
9. Distinct mechanisms of c-myc and lymphokine gene expression in an antigen specific T cell clone.
Heckford SE; Gelmann EP; Matis LA
Oncogene; 1988 Oct; 3(4):415-21. PubMed ID: 3152599
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of renal and hepatic c-myc and c-Ha-ras expression by unilateral nephrectomy.
Bailey A; Sanchez JD; Rigsby D; Roesel J; Alvarez R; Rodu B; Miller DM
Oncogene Res; 1990; 5(4):287-93. PubMed ID: 2204021
[TBL] [Abstract][Full Text] [Related]
12. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
14. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
Cleveland JL; Rapp UR; Farrar WL
J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
[TBL] [Abstract][Full Text] [Related]
15. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes.
Wingett D; Reeves R; Magnuson NS
J Immunol; 1991 Nov; 147(10):3653-9. PubMed ID: 1940364
[TBL] [Abstract][Full Text] [Related]
16. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
Klemsz MJ; Justement LB; Palmer E; Cambier JC
J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
[TBL] [Abstract][Full Text] [Related]
17. Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.
Kumagai N; Benedict SH; Mills GB; Gelfand EW
J Immunol; 1987 Sep; 139(5):1393-9. PubMed ID: 3114365
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes.
Harel-Bellan A; Ferris DK; Vinocour M; Holt JT; Farrar WL
J Immunol; 1988 Apr; 140(7):2431-5. PubMed ID: 2450923
[TBL] [Abstract][Full Text] [Related]
19. Effect of epidermal growth factor on the expression of protooncogenes c-myc and c-Ha-ras in short-term primary hepatocyte culture.
Kost DP; Michalopoulos GK
J Cell Physiol; 1990 Jul; 144(1):122-7. PubMed ID: 2195043
[TBL] [Abstract][Full Text] [Related]
20. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
Yokota S; Yuan D; Katagiri T; Eisenberg RA; Cohen PL; Ting JP
J Immunol; 1987 Oct; 139(8):2810-7. PubMed ID: 3116095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
